Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

As US pushes to ban Huawei, UK considers softer approach

Feb 21, 2019

LONDON — Britain can handle the security risks involved with using mobile networks made by China's Huawei, the cybersecurity chief said Wednesday, adding to a growing debate among countries on whether the company should be banned, as the U.S. wants. Ciaran Martin, the CEO of the U.K. National Cyber Security Centre, said it was important to have "sustainable diversity" in the supply of telecommunications equipment. He added that his agency could handle the challenges involved in monitoring suppliers who may not be considered trustworthy — a hint at Huawei. Huawei, the world's biggest maker of switching gear for phone and...

Microsoft detects hacking targeting Europe democracy groups

Feb 21, 2019

LONDON — A hacking group has targeted European democratic institutions including think tanks and non-profit groups ahead of highly anticipated EU parliamentary elections in May, Microsoft said. The company said Tuesday that a group called Strontium targeted email accounts for more than 100 people in six European countries working for the German Council on Foreign Relations, the Aspen Institutes in Europe and the German Marshall Fund. Microsoft said in a blog post that it is continuing to investigate but is confident many of the attacks originated from Strontium, a group that others call Fancy Bear or APT28. U.S. authorities have...

UK expands no-fly zone for drones around airports

Feb 21, 2019

LONDON — The no-fly zone for drones around British airports is being extended to 5 kilometers (3.1 miles) in an attempt to avert disruptions like the December groundings of flights at Gatwick Airport, officials said Wednesday. The Department for Transport said the zone will widen on March 13 from the current 1 kilometer (0.6 miles). Officials are also working on new legislation to give police more powers to stop and search people suspected of using drones maliciously. Transport Secretary Chris Grayling said people who fly drones near airports "are not only acting irresponsibly, but criminally, and could face imprisonment." More...

Twitter tightens up EU political ad rules ahead of election

Feb 21, 2019

LONDON — Twitter said Tuesday it is tightening up rules for European Union political ads ahead of bloc-wide elections this spring, following similar moves by fellow tech giants Facebook and Google. The social media company said it is extending restrictions already in place for federal elections in the United States. Under the new rules, which will also apply in Australia and India, political advertisers will need to be certified. It's also taking steps to increase transparency. Ads, in the form of "promoted tweets," from the past seven days will be stored in a publicly accessible database showing how much was...

Honda to shut plant in Brexit-shaken Britain

Feb 21, 2019

LONDON — Japanese carmaker Honda plans to close its car factory in western England in 2021, a fresh blow to the British economy as it struggles with the uncertainty associated with leaving the European Union next month. The company announced the decision, which will imperil 3,500 jobs and possibly many more, at a news conference in Tokyo. Honda's president and CEO, Takahiro Hachigo, said the decision was not related to Brexit, but was based on what made most sense for its global competitiveness in light of the need to accelerate its production of electric vehicles. Still, experts say the uncertainty...

Sign up now!